Title

Prevalence of systemic disease among COVID-19 patients admitted at Jumbo COVID care facility, Mumbai

Authors

Minal M. Kshirsagar¹, A.M Sandhya^2,*, Manjiri Deshmukh³, Priyanka Mishra⁴, Sarita Mane², Prachi Kapade⁵ & Bharat Sankhla⁶

Affiliation

¹Department of Public Health Dentistry, Bharati Vidyapeeth Dental College and Hospital, Navi Mumbai, Maharashtra, India; ²Department of General Physiology and Biochemistry, Bharati Vidyapeeth Dental College and Hospital, Navi Mumbai, Maharashtra, India; ³Department of Public Health Dentistry, Dr GD Pol Foundation YMT Dental College and Hospital-PG Institute, Khar Nagar, Navi Mumbai, Maharashtra, India; ⁴Department of Orthodontics and Dentofacial Orthopaedics, DY Patil University School of Dentistry, Navi Mumbai, Maharashtra, India; ⁵Department of Oral Pathology and Microbiology, MGV KBH Dental College and Hospital, Nashik, Maharashtra, India; ⁶Department of Oral and Maxillofacial Pathology, Government Dental College and Hospital, Jaipur, Rajasthan, India; *Corresponding author

Email

Minal M. Kshirsagar - E-mail: drminalkshirsagar12@gmail.com

A.M Sandhya- E-mail: sandhya.methal@bharatividyapeeth.edu

Manjiri Deshmukh - E-mail: deshmukh.manjiri@gmail.com

Priyanka Mishra - E-mail: drpriyankkacmishra@gmail.com

Sarita Mane - E-mail: sarita.mane@bharatividyapeeth.edu

Prachi Kapade - E-mail: prachi.7984@gmail.com

Bharat Sankhla - E-mail: drbhrt@gmail.com

Article Type

Research Article

Date

Received June 1, 2026; Revised June 30, 2026; Accepted June 30, 2026, Published June 30, 2026

Abstract

In COVID-19 existing systemic diseases aggravates the complications as well as hospitalization rates and outcomes. Therefore, it is of interest to find out how common systemic diseases are among COVID-19 patients admitted to a Jumbo COVID care facility in Mumbai. Hence, the study included 10,000 patients with confirmed COVID-19, with data from hospital records, including patient demographics and systemic diseases. Hypertension (34.8%) and diabetes (31.2%) were the most common. Identifying and managing co-morbid conditions early is important to improve outcomes and make better use of healthcare resources during pandemics.

Keywords

COVID-19, systemic diseases, co-morbidities, prevalence, cross-sectional study, Mumbai

Citation

Kshirsagar et al. Bioinformation 22(6): 3324-3327 (2026)

Edited by

Vini Mehta

ISSN

0973-2063

Publisher

Biomedical Informatics

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.